Activated leukocyte cell adhesion molecule (ALCAM or CD166) modulates bone phenotype and hematopoiesis

por Hooker, R.A., Chitteti, B.R., Egan, P.H., Cheng, Y-H., Himes, E.R., Meijome, T., Srour, E.F., Fuchs, R.K., Kacena, M.A.
Publicado 2015

High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study.

por Chabannon, C., Cornetta, K., Lotz, J. P., Rosenfeld, C., Shlomchik, M., Yanovitch, S., Marolleau, J. P., Sledge, G., Novakovitch, G., Srour, E. F., Burtness, B., Camerlo, J., Gravis, G., Lee-Fischer, J., Faucher, C., Chabbert, I., Krause, D., Maraninchi, D., Mills, B., Kunkel, L., Oldham, F., Blaise, D., Viens, P.
Publicado 1998